相关实验视频
Updated: Jun 5, 2025

Assays for Validating Histone Acetyltransferase Inhibitors
Published on: August 6, 2020
对BET抑制剂的急性耐药性通过p300联合激活重塑补偿转录程序
Viral Shah1,2,3, George Giotopoulos4,5, Hikari Osaki4,5
1Department of Hematology and Oncology, University Medical Center of the Johannes Gutenberg University, Mainz, Germany.
由于转录性可塑性,体蛋白和外端蛋白 (BET) 抑制剂在急性髓性白血病 (AML) 中表现出有限的成功. 结合BET和p300抑制可以克服这种抵抗.
科学领域:
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 急性髓性白血病 (AML) 表现出转录性可塑性,使其能够抵抗表观遗传疗法.
- 博莫多和外端蛋白 (BET) 抑制剂在AML临床试验中显示出适度的疗效.
研究的目的:
- 调查AML中BET抑制的直接表观遗传和转录反应.
- 为了确定急性和慢性抵抗BET抑制剂的机制.
主要方法:
- 在BET抑制后的染色素结合蛋白释放的分析.
- 对补偿性转录反循环的评估.
- 研究抗性适应中的p300活性.
主要成果:
- BET抑制导致通过p300介导的补偿转录反.
- 对于BET抑制剂的急性和慢性耐药性,p300活性至关重要.
- 通过p300调节的转录程序在AML亚型之间有所不同.
结论:
- 结合BET和p300抑制,提供了一种改善AML治疗结果的治疗策略.
- 顺序的BET和p300抑制可能会阻止耐药性的发展.
- 了解抗药性机制是开发更有效的AML疗法的关键.
更多相关视频
09:16Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells
Published on: September 1, 2019
10:44Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
Published on: May 15, 2019
相关概念视频
Co-activators and Co-repressors
Master Transcription Regulators
RNA Polymerase II Accessory Proteins
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Combinatorial Gene Control
The expression of more than 30,000 genes is controlled by approximately 2000-3000 transcription factors. This is possible because a single transcription factor can recognize more than one regulatory sequence. The specificity in gene...
Chromatin Modification in iPS Cells
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...